StockData
AstraZeneca PLC logo

AstraZeneca PLC (AZN) stock

AZNNYSEPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Score 12/30
$163.95−1.46 (-0.88%)

Close on Oct 19, 2026Market cap $255.76BP/E 25.1Yield 1.91%

AstraZeneca gross margin

Gross margin is gross profit as a percentage of revenue.

For fiscal 2025 it was 81.9%, against 81.1% the year before. The highest annual figure on record is 82.1% in fiscal 2016.

Annual gross margin

PeriodPeriod endValueChange (pts)
FY2025Dec 31, 202581.9%+0.8
FY2024Dec 31, 202481.1%−0.8
FY2023Dec 31, 202382.0%+9.9
FY2022Dec 31, 202272.1%+5.3
FY2021Dec 31, 202166.8%−13.3
FY2020Dec 31, 202080.1%+0.3
FY2019Dec 31, 201979.8%+2.2
FY2018Dec 31, 201877.7%−3.1
FY2017Dec 31, 201780.8%−1.3
FY2016Dec 31, 201682.1%+0.9
FY2015Dec 31, 201581.2%–

Quarterly gross margin

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange (pts)
Q2 FY2026Jun 30, 202683.6%+11.4
Q2 FY2025Jun 30, 202582.9%+9.5
Q2 FY2024Jun 30, 202483.1%−1.2
Q2 FY2023Jun 30, 202382.8%+1.1
Q2 FY2022Jun 30, 202272.2%−8.2
Q2 FY2021Jun 30, 202173.3%−9.7
Q2 FY2020Jun 30, 202084.3%–
Q2 FY2019Jun 30, 201981.7%–
Q2 FY2018Jun 30, 201880.4%–
Q2 FY2017Jun 30, 201783.0%–

More AstraZeneca figures

See a number that looks wrong?